Exclusive

Publication

Byline

Location

US Patent Issued to Children's Medical Center on June 16 for "FGF21 compositions for treatment or prevention of neovascularization of the eye and methods therefor" (Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,863, issued on June 16, was assigned to Children's Medical Center Corp. (Boston). "FGF21 compositions for treatment or prevention of neovas... Read More


US Patent Issued to Ferring on June 16 for "Recombinant FSH composition for controlled ovarian stimulation" (Danish, American Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,864, issued on June 16, was assigned to Ferring B.V. (Hoofddorp, Netherlands). "Recombinant FSH composition for controlled ovarian stimulat... Read More


US Patent Issued to Jiangsu Hengrui Pharmaceuticals on June 16 for "Dual-agonist compound for both GLP-1 and GIP receptors and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,865, issued on June 16, was assigned to Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Lianyungang, China). "Dual-agonist compound for both GLP-... Read More


US Patent Issued to Eli Lilly and Co. on June 16 for "URI agonist/vasodilator" (Indiana Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,866, issued on June 16, was assigned to Eli Lilly and Co. (Indianapolis). "URI agonist/vasodilator" was invented by Michael Patrick Akers (... Read More


US Patent Issued to Takeda Pharmaceutical on June 16 for "Lyophilized recombinant VWF formulations" (Austrian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,867, issued on June 16, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Lyophilized recombinant VWF formulations" was inven... Read More


US Patent Issued to Baylor College of Medicine on June 16 for "Uses of A2 domain of von Willebrand factor" (Texas Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,868, issued on June 16, was assigned to Baylor College of Medicine (Houston). "Uses of A2 domain of von Willebrand factor" was invented by ... Read More


US Patent Issued to Dr. Kurt Wolff on June 16 for "Composition for treatment and/or prevention of a corona virus infection" (German Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,869, issued on June 16, was assigned to Dr. Kurt Wolff GmbH & Co. KG (Bielefeld, Germany). "Composition for treatment and/or prevention of ... Read More


US Patent Issued to Novozymes on June 16 for "Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease" (Danish Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,870, issued on June 16, was assigned to Novozymes A/S (Bagsvaerd, Denmark). "Microbial lysozyme for use in the treatment of irritable bowel... Read More


US Patent Issued to BIOVERATIV THERAPEUTICS on June 16 for "Factor IX polypeptide formulations" (Massachusetts Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,871, issued on June 16, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.). "Factor IX polypeptide formulations" was invented by... Read More


US Patent Issued to AC Immune on June 16 for "Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy" (Austrian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,872, issued on June 16, was assigned to AC Immune SA (Lausanne, Switzerland). "Mimotopes of alpha-synuclein and vaccines thereof for the tr... Read More